Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study

Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study

In this multicentric real-world observational retrospective study, we evaluated the efficacy and safety of dupilumab for atopic dermatitis in children <6 years of age who underwent a minimum of 16 weeks of therapy. The analysis focused on EASI (Eczema Area and Severity Index), CDLQI (Children’s D...

Full description

Saved in:

Bibliographic Details
Main Authors:	Filip Rob, Blanka Pinkova, Kristyna Sokolova, Jana Kopuleta, Zuzana Jiraskova Zakostelska, Jana Cadova
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2025-12-01
Series:	Journal of Dermatological Treatment
Subjects:	Atopic dermatitis dupilumab biologics children efficacy safety
Online Access:	https://www.tandfonline.com/doi/10.1080/09546634.2025.2460578
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness and Safety of Dupilumab and Tralokinumab for Treating Atopic Dermatitis and Pruritic Skin Disorders in Oncological Patients: A Narrative Review
by: Lauletta G, et al.
Published: (2025-01-01)

Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study
by: Hyun Ji Lee, et al.
Published: (2025-02-01)

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
by: Tiago Torres, et al.
Published: (2024-04-01)

Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)
by: Marjolein de Bruin-Weller, et al.
Published: (2022-07-01)

Case report: Atopic dermatitis-like skin manifestations in hypohidrotic ectodermal dysplasia caused by a novel splice site mutation of the EDA gene successfully treated with dupilumab
by: Eri Uchiyama, et al.
Published: (2025-01-01)

Case Report: Severe ophiasis-pattern alopecia areata with concomitant atopic dermatitis in a 5-year-old boy successfully treated with dupilumab
by: Zhendong Wei, et al.
Published: (2025-02-01)

Safety of Dupilumab Therapy for Atopic Dermatitis during Pregnancy: A Systematic Review and Meta-analysis
by: Verónica Sánchez-García, et al.
Published: (2025-02-01)

Eosinophilic esophagitis in the “atopic march”: dupilumab as an “umbrella” strategy for multiple coexisting atopic diseases
by: Nicola Lutzu, et al.
Published: (2025-01-01)

Mistakes in the diagnosis and treatment of atopic dermatitis
by: Monika Marko, et al.
Published: (2024-02-01)

Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01)

Unmet needs in atopic dermatitis management: an expert consensus
by: Annalisa Patrizi, et al.
Published: (2022-07-01)

Determining atopic dermatitis adult patients’ preferences regarding novel systemic treatment
by: Monika Suszynska, et al.
Published: (2025-01-01)

Allergen immunotherapy in atopic dermatitis
by: Agnieszka Bogacz-Piaseczyńska, et al.
Published: (2024-08-01)

Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index
by: Gabriele Di Lorenzo, et al.
Published: (2003-01-01)

Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis
by: C. Grote, et al.
Published: (2025-12-01)

Comparative study of mouse models of atopic dermatitis
by: Siqi Ye, et al.
Published: (2025-01-01)

Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life
by: Andrew Blauvelt, et al.
Published: (2022-07-01)

The role of exogenous histamine in atopic dermatitis flare-ups
by: Zofia Kowalska, et al.
Published: (2024-08-01)

Toll-like receptors in atopic dermatitis: pathogenesis and therapeutic implications
by: Ahmad Vafaeian, et al.
Published: (2025-02-01)

A Study on the Classification of Atopic Dermatitis by Spectral Features of Hyperspectral Imaging
by: Eun Bin Kim, et al.
Published: (2025-01-01)

Atopic dermatitis in childhood and pubertal development: A nationwide cohort studyCapsule Summary
by: Camilla Lomholt Kjersgaard, MD, et al.
Published: (2025-04-01)

The epidermal lipid-microbiome loop and immunity: Important players in atopic dermatitis
by: Junchao Wu, et al.
Published: (2025-02-01)

Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database
by: Liu J, et al.
Published: (2025-02-01)

Restorative effects of camellia oil on the skin-barrier function in a model of DNCB-induced atopic dermatitis
by: Shicheng Jiao, et al.
Published: (2025-01-01)

Based on network pharmacology and molecular docking to study the mechanisms of active ingredients of ginseng in the treatment of atopic dermatitis
by: BU Jialiang, et al.
Published: (2025-01-01)

Genomic epidemiology and phenotypic characterization of Staphylococcus aureus isolated from atopic dermatitis patients in South China
by: Chao Yang, et al.
Published: (2025-02-01)

Successful Achievement of Demanding Outcomes in Upadacitinib-Treated Atopic Dermatitis Patients: A Real-World, 96-Week Single-Centre Study
by: Stamatios Gregoriou, et al.
Published: (2025-01-01)

Patients’ preferences on atopic dermatitis skincare and social media use: a qualitative study
by: Roxana Mazilu, et al.
Published: (2025-02-01)

Connecting electronic health records to a biomedical knowledge graph to link clinical phenotypes and molecular endotypes in atopic dermatitis
by: Francesca Frau, et al.
Published: (2025-01-01)

Is the Increase in Tumour Markers and Hashimoto’s Thyroiditis an Incidental Event During Dupilumab Treatment? A Case Report
by: Kesheng Lin, et al.
Published: (2025-02-01)

<i>Aspergillus oryzae</i> Fermented <i>Plumula Nelumbinis</i> Against Atopic Dermatitis Through AKT/mTOR and Jun Pathways
by: Fengfeng Chen, et al.
Published: (2024-12-01)

A Comparative Study to Evaluate the Effectiveness between Synergic Activities of 0.1% Polyhexanide and Rigenase® (Fitostimoline® Plus spray) versus a Hydrating Formulation for the Topical Management of Rubbing Injuries Secondary to Atopic Dermatitis
by: Eugenia Veronica Di Brizzi, et al.
Published: (2025-01-01)

Thymus and activation-regulated chemokine (CCL17) as a clinical biomarker in atopic dermatitis: significance and limitations in the new treatment era
by: Yoko Kataoka
Published: (2025-01-01)

Dupilumab in children with eosinophilic esophagitis: a retrospective multicenter study
by: Mohammed Hasosah, et al.
Published: (2025-02-01)

Anti-inflammatory and antioxidant properties of Camellia sinensis L. extract as a potential therapeutic for atopic dermatitis through NF-κB pathway inhibition
by: Min Jung Kim, et al.
Published: (2025-01-01)

The Anti-Inflammatory Effect of Chenopodium Murale in Comparison to Salvia Frigida on Atopic Eczema
by: Zahraa Y. Hassan, et al.
Published: (2024-12-01)

Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children
by: Eric L. Simpson, et al.
Published: (2025-01-01)

Effectiveness of dupilumab treatment against refractory eosinophilic chronic rhinosinusitis
by: Daiki Nakashima, MD, et al.
Published: (2025-05-01)

Exploration of the mechanism of Lithospermum erythrorhizon oil in treating atopic dermatitis based on network pharmacology and experimental validation of the PI3K-Akt pathway regulation
by: Weisheng Hu, et al.
Published: (2025-01-01)

Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps
by: Shaun J. Kilty, et al.
Published: (2022-04-01)